Viral clearance considerations for continuous viral inactivation
September 17-21, 2017
Continuous low pH viral inactivation has been considered by Boehringer Ingelheim, Pfizer, and other companies who are investing in integrated processing. In continuous viral inactivation, a critical parameter that poses a new challenge is the exact incubation time of the product stream. In a continuous space, the concept of time translates in the product flow rate, incubation volume, and dispersion effects. To address dispersion, we define the minimum residence time, tmin, as the time when the first product element exits the tubular chamber. In this work, we characterize the tmin for a novel, scalable, and sturdy tubular reactor design that can serve as an incubation chamber for a process capable to produce >1kg of product. In addition, we provide robust data for a scale down model suitable for viral studies. We propose an innovative in-line spiking methodology to validate the minimum residence time using viruses. This methodology can be used as a viral clearance platform for continuous low pH virus inactivation. Finally, we propose a trace response method to be used as a way to verify that the process was properly set up.
Raquel Orozco, Linus Amarikwa, Stephanie Parker, Scott Godfrey, Marcus Fiadeiro, Rob Fahrner, Jeff Salm, and Jon Coffman, "Viral clearance considerations for continuous viral inactivation" in "Integrated Continuous Biomanufacturing III", Suzanne Farid, University College London, United Kingdom Chetan Goudar, Amgen, USA Paula Alves, IBET, Portugal Veena Warikoo, Axcella Health, Inc., USA Eds, ECI Symposium Series, (2017). http://dc.engconfintl.org/biomanufact_iii/27
This document is currently not available here.